Aytu BioPharma (AYTU) 10-Q2012 Q1 Quarterly report

Filed: 23 Dec 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade V good

New words: adapt, APPROVAL, approve, approved, assist, board, CAPABLE, consummate, consummated, December, disapprove, dive, editorial, enter, expansion, HAM, law, light, load, magazine, MERGER, Mexico, Northwest, ongoing, OUTSTANDING, Pacific, par, PRIMARY, radio, ran, recruit, REVERSE, RT, season, smaller, staffing, stand, TOWNSEND, transaction, UNAFFILIATED, uncertainty, UNRELATED, WASHINGTON

Removed: advertising, anticipate, approximately, Australia, average, bank, cease, client, committed, CONSISTANTLY, consistently, converted, escrow, Initial, initiate, japan, making, NASD, offering, Part, sustaining, team, transferred, Unanticipated, uninsured, unsecured, upgrade

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AYTU similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, James B. Wiegand, Chief Executive Officer of Rosewind Corporation (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended November 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: December 23, 2011	By:	/s/ James B. Wiegand
		James B. Wiegand
		Principal Executive Officer and Principal Financial Officer